Isonics Corporation (ISON)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Isonics Corporation (ISON) with AI Score 38/100 (Weak). Isonics Corporation operates in the Homeland Security and Defense, Semiconductor, and Life Sciences sectors. Market cap: 0, Sector: Industrials.
Last analyzed: Mar 15, 2026Isonics Corporation (ISON) Industrial Operations Profile
Isonics Corporation serves the Homeland Security, Semiconductor, and Life Sciences industries, offering security services, wafer reclamation, and isotopes. The company focuses on developing solutions for asset protection, providing high-quality wafer services, and supplying isotopes for cancer imaging and treatment, positioning itself as a diversified industrial player.
Investment Thesis
Isonics Corporation operates in diverse sectors, including Homeland Security, Semiconductor, and Life Sciences. Key value drivers include the growing demand for security services, the increasing need for wafer reclamation in the semiconductor industry, and the expanding use of isotopes in healthcare. Growth catalysts involve strategic partnerships and expansion of service offerings within each division. Potential risks include market volatility, competition, and regulatory changes affecting the security, semiconductor, and healthcare industries. Investors should monitor the company's ability to innovate, secure contracts, and maintain regulatory compliance to assess its long-term growth potential.
Based on FMP financials and quantitative analysis
Key Highlights
- Operates in three divisions: Homeland Security and Defense, Semiconductor, and Life Sciences.
- Offers security services for businesses and institutions in healthcare, education, retail, manufacturing, banking, and art industries.
- Specializes in high-quality wafer reclaim, test wafer production, wafer thinning, and custom wafer services with a focus on the 300mm market.
- Markets and sells isotopes to the healthcare industry for the imaging and treatment of cancer.
- Founded in 1992 and based in Golden, Colorado.
Strengths
- Diversified business model across multiple sectors.
- Expertise in security services, wafer processing, and isotope technology.
- Focus on high-quality wafer reclaim and custom wafer services.
- Established presence in the Homeland Security, Semiconductor, and Life Sciences markets.
Weaknesses
- Small market capitalization.
- Limited financial resources compared to larger competitors.
- Dependence on specific contracts and projects for revenue generation.
- Potential vulnerability to market volatility and economic downturns.
Catalysts
- Upcoming: Expansion of security service offerings to address growing demand for asset protection.
- Upcoming: Development of new isotope products for healthcare applications.
- Ongoing: Strategic partnerships to enhance capabilities and market reach.
- Ongoing: Increasing wafer reclamation services in the semiconductor industry.
- Ongoing: Focus on high-quality wafer reclaim and custom wafer services for the 300mm market.
Risks
- Potential: Competition from larger and more established companies in the security, semiconductor, and healthcare sectors.
- Potential: Regulatory changes affecting the security, semiconductor, and healthcare industries.
- Ongoing: Economic downturns impacting demand for security services and semiconductor products.
- Ongoing: Technological advancements rendering existing products and services obsolete.
- Potential: Limited financial resources compared to larger competitors.
Growth Opportunities
- Growth opportunity 1: Expanding Homeland Security Services: The increasing demand for security solutions in various sectors, including healthcare and education, presents a significant growth opportunity for Isonics. By developing advanced security technologies and expanding its service offerings, Isonics can capitalize on the growing market for asset protection and risk management. This expansion could lead to increased revenue and market share in the security services industry.
- Growth opportunity 2: Semiconductor Wafer Reclamation: The semiconductor industry's focus on cost reduction and environmental sustainability drives the demand for wafer reclamation services. Isonics can leverage its expertise in wafer thinning and custom wafer services to expand its market share in the 300mm wafer market. This growth opportunity involves investing in advanced equipment and technologies to enhance wafer reclamation capabilities.
- Growth opportunity 3: Life Sciences Isotope Sales: The increasing use of isotopes in cancer imaging and treatment presents a growth opportunity for Isonics in the Life Sciences sector. By expanding its isotope product line and distribution network, Isonics can increase its sales to healthcare providers and research institutions. This growth opportunity requires regulatory compliance and strategic partnerships with healthcare organizations.
- Growth opportunity 4: Strategic Partnerships: Forming strategic alliances with technology providers and industry leaders can enhance Isonics' capabilities and market reach. Collaborations with security technology companies, semiconductor manufacturers, and healthcare organizations can drive innovation and expand the company's service offerings. These partnerships can lead to new revenue streams and competitive advantages.
- Growth opportunity 5: Geographic Expansion: Expanding its operations to new geographic markets can drive growth for Isonics. By targeting regions with high demand for security services, semiconductor manufacturing, and healthcare solutions, Isonics can increase its customer base and revenue. This expansion requires market research, regulatory compliance, and strategic investments in infrastructure and personnel.
Opportunities
- Expanding security service offerings to address growing demand.
- Increasing wafer reclamation services in the semiconductor industry.
- Developing new isotope products for healthcare applications.
- Forming strategic partnerships to enhance capabilities and market reach.
Threats
- Competition from larger and more established companies.
- Regulatory changes affecting the security, semiconductor, and healthcare industries.
- Economic downturns impacting demand for security services and semiconductor products.
- Technological advancements rendering existing products and services obsolete.
Competitive Advantages
- Established expertise in security services, wafer processing, and isotope technology.
- Diversified business model across Homeland Security, Semiconductor, and Life Sciences sectors.
- Focus on high-quality wafer reclaim and custom wafer services for the 300mm market.
About ISON
Founded in 1992 and based in Golden, Colorado, Isonics Corporation (formerly A&R Materials, Inc.) operates across three divisions: Homeland Security and Defense, Semiconductor, and Life Sciences. The Homeland Security and Defense division develops solutions to protect and secure assets for clients, offering security services to businesses and institutions in healthcare, education, retail, manufacturing, banking, and art industries. The Semiconductor division specializes in wafer reclaim, test wafer production, wafer thinning, and custom wafer services, focusing on the 300mm market. The Life Sciences division markets and sells isotopes to the healthcare industry for cancer imaging and treatment. Isonics aims to provide comprehensive solutions across these sectors, leveraging its expertise in security, semiconductor services, and isotope technology. The company's evolution reflects a diversification strategy to address various industrial and healthcare needs.
What They Do
- Offers homeland security products and services to protect assets and resources.
- Provides security services for businesses and institutions in various industries.
- Specializes in high-quality wafer reclaim and test wafer production.
- Offers wafer thinning and custom wafer services for the semiconductor industry.
- Markets and sells isotopes to the healthcare industry for cancer imaging and treatment.
- Focuses on the 300mm wafer market within the semiconductor division.
Business Model
- Generates revenue through security service contracts with businesses and institutions.
- Earns income from wafer reclaim, thinning, and custom services provided to semiconductor manufacturers.
- Sells isotopes to healthcare providers and research institutions for medical applications.
Industry Context
Isonics Corporation operates within the Specialty Business Services industry, serving the Homeland Security, Semiconductor, and Life Sciences sectors. The security services market is driven by increasing threats and the need for asset protection. The semiconductor industry relies on wafer reclamation to reduce costs and environmental impact. The healthcare sector utilizes isotopes for medical imaging and treatment. Isonics competes with companies offering similar services and products in each sector, requiring continuous innovation and strategic partnerships to maintain a competitive edge.
Key Customers
- Businesses and institutions in healthcare, education, retail, manufacturing, banking, and art industries.
- Semiconductor manufacturers requiring wafer reclaim and custom wafer services.
- Healthcare providers and research institutions using isotopes for cancer imaging and treatment.
Financials
Chart & Info
Isonics Corporation (ISON) stock price: Price data unavailable
Latest News
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ISON.
Price Targets
Wall Street price target analysis for ISON.
MoonshotScore
What does this score mean?
The MoonshotScore rates ISON's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Specialty Business ServicesLeadership: Christopher Toffales
CEO
Christopher Toffales serves as the CEO of Isonics Corporation, managing a team of 384 employees. Information regarding his detailed career history, education, and previous roles is not available. His leadership is crucial in guiding Isonics across its Homeland Security and Defense, Semiconductor, and Life Sciences divisions, focusing on strategic growth and operational efficiency.
Track Record: Due to limited information on Christopher Toffales' specific achievements and strategic decisions at Isonics, a comprehensive track record cannot be established. Assessing his impact on key company milestones requires further data on his leadership during specific periods and projects.
ISON OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Isonics Corporation may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and operational performance. Unlike NYSE or NASDAQ listings, OTC Other stocks often lack stringent listing requirements, resulting in increased risk for investors.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure and transparency.
- Lower trading volume and liquidity.
- Wider bid-ask spreads.
- Potential for price manipulation and fraud.
- Higher risk of delisting or suspension of trading.
- Verify the availability and accuracy of financial statements.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Review the company's legal and regulatory compliance.
- Monitor trading volume and price volatility.
- Understand the risks associated with OTC investing.
- Consult with a financial advisor before investing.
- Established business operations in multiple sectors.
- Long operating history since 1992.
- Presence in the Homeland Security, Semiconductor, and Life Sciences markets.
- Focus on high-quality wafer reclaim and custom wafer services.
Isonics Corporation Stock: Key Questions Answered
What does Isonics Corporation do?
Isonics Corporation operates across three divisions: Homeland Security and Defense, Semiconductor, and Life Sciences. The company offers security services to businesses and institutions, specializing in high-quality wafer reclaim, test wafer production, wafer thinning, and custom wafer services for the semiconductor industry. Additionally, Isonics markets and sells isotopes to the healthcare industry for cancer imaging and treatment, positioning itself as a diversified industrial player with a focus on security, semiconductor services, and isotope technology.
What do analysts say about ISON stock?
AI analysis is pending for ISON, and therefore a comprehensive analyst consensus is not currently available. Investors should monitor for updates on analyst ratings, price targets, and financial forecasts. Key valuation metrics to consider include revenue growth, gross margin, and earnings per share. Growth considerations involve the company's ability to expand its service offerings, secure contracts, and maintain regulatory compliance across its Homeland Security, Semiconductor, and Life Sciences divisions.
What are the main risks for ISON?
Isonics Corporation faces several risks, including competition from larger and more established companies in the security, semiconductor, and healthcare sectors. Regulatory changes in these industries could also impact the company's operations and financial performance. Economic downturns may reduce demand for security services and semiconductor products. Additionally, technological advancements could render existing products and services obsolete, requiring continuous innovation and investment in research and development.
What are the key factors to evaluate for ISON?
Isonics Corporation (ISON) currently holds an AI score of 38/100, indicating low score. Key strength: Diversified business model across multiple sectors.. Primary risk to monitor: Potential: Competition from larger and more established companies in the security, semiconductor, and healthcare sectors.. This is not financial advice.
How frequently does ISON data refresh on this page?
ISON prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven ISON's recent stock price performance?
Recent price movement in Isonics Corporation (ISON) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diversified business model across multiple sectors.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider ISON overvalued or undervalued right now?
Determining whether Isonics Corporation (ISON) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying ISON?
Before investing in Isonics Corporation (ISON), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on CEO track record and analyst coverage.
- OTC market investments carry higher risks due to lower liquidity and disclosure requirements.